D'Hondt Matthias, Gevaert Bert, Wynendaele Evelien, De Spiegeleer Bart
Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
J Pharm Anal. 2016 Feb;6(1):24-31. doi: 10.1016/j.jpha.2015.09.002. Epub 2015 Sep 26.
A newly developed single quad mass spectrometry (MS) detector was coupled to a ultra-high performance liquid chromatography (UPLC) system and implemented in the routine quality control (QC) and impurity analysis of four therapeutic peptides, namely bleomycin sulfate, tyrothricin, vancomycin HCl and bacitracin, which were selected given their multi-component drug nature and their closely structurally related impurity profiles. The QC and impurity profiling results obtained using the ultra-high performance liquid chromatography ultraviolet/mass spectrometry (UPLC-UV/MS) detection system were analyzed against the results obtained using traditional high performance liquid chromatography-ultraviolet detection (HPLC-UV) methods derived from pharmacopoeial methods. In general, the used stationary phases of sub-2 µm particle (UPLC) technology resulted in lower limits of detection and higher resolution separations, which resulted in more detected impurities and shorter overall run times contrasting the traditional HPLC columns. Moreover, online coupling with a single quad MS detector allowed direct peak identification of the main compounds as well as small impurities, hereby increasing the information content without the need of reference standards.
一种新开发的单四极杆质谱(MS)检测器与超高效液相色谱(UPLC)系统联用,并应用于四种治疗性肽(即硫酸博来霉素、短杆菌肽、盐酸万古霉素和杆菌肽)的常规质量控制(QC)和杂质分析。选择这四种肽是鉴于它们的多组分药物性质以及其结构密切相关的杂质谱。将使用超高效液相色谱紫外/质谱(UPLC-UV/MS)检测系统获得的QC和杂质剖析结果与使用源自药典方法的传统高效液相色谱-紫外检测(HPLC-UV)方法获得的结果进行对比分析。总体而言,亚2 µm颗粒(UPLC)技术所使用的固定相导致检测限更低且分离度更高,这使得检测到的杂质更多,与传统HPLC柱相比,总运行时间更短。此外,与单四极杆MS检测器的在线联用允许直接对主要化合物以及小杂质进行峰识别,从而在无需参考标准品的情况下增加了信息含量。